AAV-mediated RGS6 re-expression in SNpc after pathology onset

Mechanistic description

Restore RGS6 in substantia nigra pars compacta dopaminergic neurons after established alpha-synuclein pathology to test whether RGS6 loss is not only necessary but therapeutically reversible. The decisive experiment is delayed intervention in PFF or AAV-SNCA models with unbiased stereology, terminal preservation, dopamine physiology, and catalytically dead RGS6 controls.

Mechanism / pathway

RGS6
→
neurodegeneration

Evidence for (7)

RGS6 deficiency causes age-dependent nigral dopaminergic degeneration, alpha-synuclein accumulation, hyperactive D2 autoreceptor signaling, and reduced cAMP signaling, making RGS6 restoration the most direct therapeutic test of the causal axis.

PMID:31120439
Earlier mouse work independently linked loss of Rgs6 to Parkinsonian dopaminergic pathology, supporting necessity of endogenous RGS6 for nigrostriatal integrity.

PMID:25568967
RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis.

PMID:23995786 2014 Oncogene
Regulator of G protein signaling 6 mediates exercise-induced recovery of hippocampal neurogenesis, learning, and memory in a mouse model of Alzheimer's disease.

PMID:39248184 2025 Neural Regen Res
RGS6 drives cardiomyocyte death following nucleolar stress by suppressing Nucleolin/miRNA-21.

PMID:38409136 2024 J Transl Med
RGS6 mediates exercise-induced recovery of hippocampal neurogenesis, learning, and memory in an Alzheimer's mouse model.

PMID:39185171 2023 bioRxiv
RGS6 suppresses TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with SMAD4.

PMID:35902557 2022 Cell Death Dis

Evidence against (3)

Loss-of-function necessity does not establish that gain-of-function is safe or sufficient, especially once degeneration is established.

PMID:31120439
RGS6 has been reported to promote mitochondrial and caspase-linked apoptosis in other systems, raising a nontrivial safety liability for overexpression.

PMID:21041304
Additional studies also support pro-apoptotic RGS6 signaling, reinforcing concern that overexpression could worsen neuronal loss rather than rescue it.

PMID:23338613

Evidence matrix

7 supporting 3 contradicting

53% posterior support

Supporting

RGS6 deficiency causes age-dependent nigral dopaminergic degeneration, alpha-synuclein accumulation, hyperactive D2 autoreceptor signaling, and reduced cAMP signaling, making RGS6 restoration the most direct therapeutic test of the causal axis. PMID:31120439
Earlier mouse work independently linked loss of Rgs6 to Parkinsonian dopaminergic pathology, supporting necessity of endogenous RGS6 for nigrostriatal integrity. PMID:25568967
RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis. PMID:23995786 · 2014 · Oncogene
Regulator of G protein signaling 6 mediates exercise-induced recovery of hippocampal neurogenesis, learning, and memory in a mouse model of Alzheimer's disease. PMID:39248184 · 2025 · Neural Regen Res
RGS6 drives cardiomyocyte death following nucleolar stress by suppressing Nucleolin/miRNA-21. PMID:38409136 · 2024 · J Transl Med
RGS6 mediates exercise-induced recovery of hippocampal neurogenesis, learning, and memory in an Alzheimer's mouse model. PMID:39185171 · 2023 · bioRxiv
RGS6 suppresses TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with SMAD4. PMID:35902557 · 2022 · Cell Death Dis

Contradicting

Loss-of-function necessity does not establish that gain-of-function is safe or sufficient, especially once degeneration is established. PMID:31120439
RGS6 has been reported to promote mitochondrial and caspase-linked apoptosis in other systems, raising a nontrivial safety liability for overexpression. PMID:21041304
Additional studies also support pro-apoptotic RGS6 signaling, reinforcing concern that overexpression could worsen neuronal loss rather than rescue it. PMID:23338613

Bayesian persona consensus

53% posterior support

1 signal · 1 for / 0 against · agreement 100%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). AAV-mediated RGS6 re-expression in SNpc after pathology onset. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-c98d1cb4e7

BibTeX

@misc{scidex_hypothesis_hc98d1cb,
  title        = {AAV-mediated RGS6 re-expression in SNpc after pathology onset},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-c98d1cb4e7},
  note         = {SciDEX artifact hypothesis:h-c98d1cb4e7}
}